-The Economic Times Should drug companies make clinical trials data public? All over the world, drug regulators are increasingly in favour of doing so, much to the discomfort of pharmaceutical companies, and the London-based European Medicines Agency (EMA) is the first mover in this regard. As the journal Nature reports, EMA is likely to do so by next year, at least for some clinical trials data. On April 19, all the...
More »SEARCH RESULT
Total Matching Records found : 1109
Novartis order may force pharma MNCs to change
-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...
More »Even after three years, RTE fails to deliver-Aarti Dhar
-The Hindu On Monday, the Right of Children to Free and Compulsory Education Act, 2009, completes three years of its existence - the time frame within which authorities were to ensure that its provisions were fully implemented - to make basic education a legal entitlement to all children aged 6-14. However, official statistics and reports from the field paint a far-from satisfactory picture, with citizens moving court against the competent authority...
More »Government close to giving up on Aakash project- Prashant K Nanda and Surabhi Agarwal
-Live Mint HRD minister Pallam Raju says focus should be on helping students access content, not on hardware The government seems to have virtually given up onAakash, the $35 tablet computer that was once billed as India's low-cost solution for bridging the divide between digital haves and have-nots. "Let's not get obsessed with hardware," human resource development (HRD) minister M.M. Pallam Raju said on Friday. "The overall (issue) is how we enable students....
More »European Union-India FTA may hit generic medical industry-Rema Nagarajan
-The Times of India The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade...
More »
